Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Payables (2016 - 2025)

Healthy Extracts' Payables history spans 11 years, with the latest figure at $219826.0 for Q4 2025.

  • For Q4 2025, Payables rose 302.06% year-over-year to $219826.0; the TTM value through Dec 2025 reached $219826.0, up 302.06%, while the annual FY2025 figure was $219826.0, 302.06% up from the prior year.
  • Payables reached $219826.0 in Q4 2025 per HYEX's latest filing, down from $231963.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $887908.0 in Q3 2021 to a low of $54675.0 in Q4 2024.
  • Average Payables over 5 years is $412708.8, with a median of $402390.0 recorded in 2021.
  • Peak YoY movement for Payables: surged 1431.67% in 2021, then crashed 88.56% in 2024.
  • A 5-year view of Payables shows it stood at $209017.0 in 2021, then skyrocketed by 95.49% to $408600.0 in 2022, then rose by 16.97% to $477935.0 in 2023, then plummeted by 88.56% to $54675.0 in 2024, then surged by 302.06% to $219826.0 in 2025.
  • Per Business Quant, the three most recent readings for HYEX's Payables are $219826.0 (Q4 2025), $231963.0 (Q3 2025), and $270152.0 (Q2 2025).